Apollomics Inc. SEC filings APLM
Apollomics Inc. has 183 filings in SEC EDGAR's recent list, going back to Sep 14, 2022. Its latest annual report, Form 20-F, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Aug 12, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4/A | Filing | Sep 24, 2026 | Sep 14, 2026 |
| 4/A | Filing | Sep 24, 2026 | Sep 14, 2026 |
| 4/A | Filing | Sep 24, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Sep 17, 2026 | Sep 14, 2026 |
| 4 | Insider transaction | Aug 24, 2026 | Aug 17, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 14, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 17, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 14, 2026 | — |
| 3 | Initial insider ownership | Jul 24, 2026 | Jul 20, 2026 |
| 4 | Insider transaction | Jun 17, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 4 | Insider transaction | May 19, 2026 | May 17, 2026 |
| 3/A | Filing | Apr 17, 2026 | Mar 18, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Mar 31, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 18, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 18, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 18, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 19, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 18, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 18, 2026 |
| 3/A | Filing | Apr 14, 2026 | Mar 18, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Apr 8, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 6, 2026 | — |
| 3 | Initial insider ownership | Mar 19, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 18, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Sep 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 5, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 10, 2025 | — |
| SC 13D/A | Amended ownership over 5% (active) | Aug 15, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | May 30, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | May 22, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | May 20, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 27, 2024 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 29, 2023 | — |
| 144 | Notice of proposed sale | Nov 27, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 20, 2023 | — |
| 144 | Notice of proposed sale | Nov 16, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Nov 1, 2023 | — |
| 144 | Notice of proposed sale | Oct 30, 2023 | — |
| SC 13D | Ownership over 5% (active) | Oct 10, 2023 | — |
| 144 | Notice of proposed sale | Oct 5, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Oct 2, 2023 | — |
| SC 13D | Ownership over 5% (active) | Apr 12, 2023 | — |
Showing 63 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- APLM (Nasdaq), APLMW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Covina, CA
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1944885
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.